A new dopamine‐β‐hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L‐DOPA in the spinal cord [PDF]
N.‐E. Andén, Kjell Fuxé
openalex +1 more source
Effect of Hewei Anshen Decoction on depressive insomnia and brain neurotransmitter levels
Abstract Objective To evaluate the therapeutic effect of Hewei Anshen Decoction (HAD) on both depressive symptoms and sleep quality in patients with depressive insomnia, and to investigate its impact on brain neurotransmitter levels. Methods Seventy‐two patients with depressive insomnia were randomly assigned to a treatment group and a control group ...
Feifei Lv +4 more
wiley +1 more source
Beyond neurons: astrocytic ensembles stabilize memories after recall. [PDF]
Bakr M, Salama M.
europepmc +1 more source
Possible mechanisms underlying the midazolam‐induced relaxation of the noradrenaline‐contraction in rabbit mesenteric resistance artery [PDF]
Yoshihisa Shiraishi +5 more
openalex +1 more source
We present a heart‐on‐a‐chip platform embedded with ultrasoft mechanosensors for real‐time, multi‐scale stress mapping in engineered cardiac tissues. The system enables simultaneous quantification of local cell‐generated stresses and global tissue contractile forces.
Ali Mousavi +10 more
wiley +1 more source
6-Nitrodopamine Release From Mouse Seminal Vesicles Is Dependent on Endothelial Nitric Oxide Synthase (eNOS) Activation. [PDF]
Britto-Júnior J +12 more
europepmc +1 more source
Noradrenaline-secreting Neuroblastomata [PDF]
H, ISAACS, M, MEDALIE, W M, POLITZER
openaire +2 more sources
Mesoporous Materials for Electrochemical Biosensors: From Broad Structure to Silica Film
This review showcases how mesoporous materials advance biosensing, spanning from material classes and fabrication strategies to the unique role of silica films as functional sensing platforms. With tunable porosity, high surface area, and versatile chemistry, these materials enhance selectivity and signal amplification in biosensors.
Vinh Khanh Ho +3 more
wiley +1 more source
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy? [PDF]
Durcan R, O'Callaghan C, Rowe JB.
europepmc +1 more source

